EQUITY RESEARCH MEMO

Vibrant America Clinical Laboratory

Generated 5/3/2026

Executive Summary

Conviction (model self-assessment)50/100

Vibrant America Clinical Laboratory is a privately held diagnostics company headquartered in San Carlos, California, founded in 2017. The company operates a CLIA and CAP-certified laboratory offering a broad menu of clinical tests, with a strategic emphasis on autoimmune diagnostics using multiplexing technology to improve efficiency and turnaround times. Serving physicians, patients, and hospitals across all 50 states, Vibrant America differentiates itself through affordability, rapid results, and a web-based reporting platform. While the company has not disclosed fundraising or valuation details, its focus on a high-growth area (autoimmune testing) and nationwide reach position it as a potential player in the U.S. diagnostics market. However, the lack of public financial data and limited visibility into partnerships or clinical adoption constrain the confidence in its near-term trajectory.

Upcoming Catalysts (preview)

  • Q4 2026Expansion of autoimmune test menu with new FDA-cleared assays60% success
  • H2 2026Strategic partnership with a major hospital network or reference lab40% success
  • Q3 2026Series A or B funding round to scale operations50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)